Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains - PubMed (original) (raw)
Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains
L Pulliam et al. J Clin Invest. 1991 Feb.
Abstract
We wanted to establish an in vitro human model for AIDS-associated dementia and pursue the hypothesis that this disease process may be a result of soluble factors produced by HIV-infected macrophages. Human brain aggregates were prepared from nine different brain specimens, and were treated with supernatants from in vitro HIV-infected macrophages (SI), uninfected macrophages (SU), infected T cells, or macrophage-conditioned media from four AIDS patients. Seven of nine treated brains exposed to SI showed peripheral rarefaction after 1 wk of incubation that by ultrastructural analysis showed cytoplasmic vacuolation. Aggregates from two of three brain cultures treated with SI for 3 wk became smaller, an approximately 50% decrease in size. The degree of apparent toxicity in brains exposed to patient-derived macrophage supernatants paralleled the proportion of macrophages found to be expressing HIV p24. Ultrastructural abnormalities were not observed in brains treated with supernatants from HIV-infected T cells, uninfected macrophages, or LPS-activated macrophages. Levels of five neurotransmitter amino acids were decreased in comparison to the structural amino acid leucine. These findings suggest that HIV-infected macrophages, infected both in vitro as well as derived from AIDS patients' peripheral blood, produce factors that cause reproducible histochemical, ultrastructural, and functional abnormalities in human brain aggregates.
Similar articles
- Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.
Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD. Power C, et al. Ann Neurol. 1993 Sep;34(3):339-50. doi: 10.1002/ana.410340307. Ann Neurol. 1993. PMID: 7689819 - Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.
Epstein LG, Gendelman HE. Epstein LG, et al. Ann Neurol. 1993 May;33(5):429-36. doi: 10.1002/ana.410330502. Ann Neurol. 1993. PMID: 8498818 Review. - OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis.
Carlson KA, Limoges J, Pohlman GD, Poluektova LY, Langford D, Masliah E, Ikezu T, Gendelman HE. Carlson KA, et al. J Neuroimmunol. 2004 May;150(1-2):186-98. doi: 10.1016/j.jneuroim.2004.01.021. J Neuroimmunol. 2004. PMID: 15081264 - Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
Kramer-Hämmerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R. Kramer-Hämmerle S, et al. Virus Res. 2005 Aug;111(2):194-213. doi: 10.1016/j.virusres.2005.04.009. Virus Res. 2005. PMID: 15885841 Review.
Cited by
- Cerebrospinal fluid cytokines in AIDS dementia complex.
Perrella O, Carrieri PB, Guarnaccia D, Soscia M. Perrella O, et al. J Neurol. 1992 Aug;239(7):387-8. doi: 10.1007/BF00812156. J Neurol. 1992. PMID: 1403021 - Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.
Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J. Cotter R, et al. J Neurovirol. 2002 Dec;8(6):585-98. doi: 10.1080/13550280290100950. J Neurovirol. 2002. PMID: 12476352 Review. - Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes.
Deisenhammer F, Miller RF, Brink NS, Harrison MJ, Thompson EJ. Deisenhammer F, et al. Genitourin Med. 1997 Jun;73(3):181-3. doi: 10.1136/sti.73.3.181. Genitourin Med. 1997. PMID: 9306897 Free PMC article. - HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.
Lipton SA. Lipton SA. Mol Neurobiol. 1994 Apr-Jun;8(2-3):181-96. doi: 10.1007/BF02780669. Mol Neurobiol. 1994. PMID: 7999315 Review. - Involvement of the p53 and p73 transcription factors in neuroAIDS.
Mukerjee R, Deshmane SL, Fan S, Del Valle L, White MK, Khalili K, Amini S, Sawaya BE. Mukerjee R, et al. Cell Cycle. 2008 Sep 1;7(17):2682-90. doi: 10.4161/cc.7.17.6450. Epub 2008 Sep 17. Cell Cycle. 2008. PMID: 18719392 Free PMC article.
References
- J Clin Invest. 1988 Dec;82(6):2097-105 - PubMed
- Science. 1989 May 19;244(4906):798-800 - PubMed
- J Neurosci Methods. 1987 May;20(1):83-90 - PubMed
- Nature. 1988 Oct 13;335(6191):639-42 - PubMed
- Ann Neurol. 1986 Jun;19(6):525-35 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources